UB scientists exploring the nature of immunity after vaccination against Streptococcus pneumoniae, which causes pneumonia in people, have discovered that a specific type of white blood cell called ...

Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage. Yet despite their importance, until now very little was known about how they truly ...

Using a protein nanoparticle they designed, scientists at the University of Illinois Chicago have identified two distinct subtypes of neutrophils and found that one of the subtypes can be used as a ...

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, these cells are also active in autoimmune diseases. New research from Japan ...

Researchers from Universidad Carlos III de Madrid (UC3M), the National Center for Cardiovascular Research (CNIC), and Yale University (USA) have published a comprehensive review article in the journal ...

In a recent Nature Reviews Immunology journal study, researchers assess the role of neutrophil extracellular traps (NETs) in systemic autoimmune and autoinflammatory disorders. Study: Neutrophil ...

Although the cloak of invisibility only exists in fictional stories, solid tumors have generated a tumor microenvironment (TME) that simulates a biological cloak of invisibility in which tumor cells ...

Sarcomas are a group of rare mesenchymal tumors that account for less than 1% of adult solid malignancies, but represent 21% of pediatric solid malignancies 1. While the incidence is low relative to ...

DNA emerging from activated neutrophils to extracellular space is stained by Sytox Green, a plasma membrane-impermeable DNA dye (0-120 min after stimulation). When harmful bacteria or other ...

RNA is thought to be a stay-at-home kind of molecule, often comfortably confined within the cell’s interior. So, when RNA molecules were detected on the surface of several cell types, researchers ...

Pancreatic ductal adenocarcinoma (PDAC) patients have a 5-year survival rate of only 8% largely due to late diagnosis and insufficient therapeutic options. Neutrophils are among the most abundant ...